Chambers ES, Morrison DJ, Frost G
One year after stopping tirzepatide, 46% of people still managed to keep off at least 10% of their weight, and almost 25% of people kept off at least 15%

Breaking down the numbers further: 5% weight loss achieved : 95% with tirzepatide vs 79% with semaglutide 10% weight loss achieved : 89% with tirzepatide vs 61% with semaglutide 15% weight loss achieved : 77% with tirzepatide vs 39% with semaglutide 20% weight loss achieved : 62% with tirzepatide vs 23% with semaglutide Diabetes Management For patients with type 2 diabetes, both medications offer significant benefits, though tirzepatide shows a slight edge: HbA1c reduction : Tirzepatide typically lowers HbA1c by 2-2.5%, while semaglutide achieves 1-2% reduction Fasting glucose improvement : Both medications effectively lower fasting blood sugar Time in range : Patients on both medications spend more time with blood sugars in the target range Insulin sensitivity : Tirzepatide may provide greater improvements in insulin sensitivity Cardiovascular Benefits Semaglutide has established cardiovascular benefits with FDA approval for reducing heart attack, stroke, and cardiovascular death risk in patients with type 2 diabetes or obesity with established heart disease

PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 peptide pathways and 150+ genetic insights including your GIPR status
Semaglutide and high-intensity interval exercise attenuate cognitive impairment in type 2 diabetic mice via BDNF modulation